Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Bellerophon (BLPH)
NASDAQ:BLPH
Bellerophon (BLPH) Stock Price & Analysis
490 Followers
BLPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.67 - $12.58
Previous Close$6.89
Volume19.29K
Average Volume (3M)1.26M
Market Cap
$72.00M
Enterprise Value$56.40M
Total Cash (Recent Filing)$15.61M
Total Debt (Recent Filing)$8.00K
Price to Earnings (P/E)-5.7
Beta-0.15
Next Earnings
Aug 03, 2023EPS Estimate
-$0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.22
Shares Outstanding10,449,834
10 Day Avg. Volume162,664
30 Day Avg. Volume1,255,300
Standard Deviation0.50
R-Squared0.00939
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)12.89
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)5.50
P/FCF Ratio5.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.72
Forecast
1Y Price Target
$32.50Price Target Upside371.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bellerophon News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLPH FAQ
What was Bellerophon’s price range in the past 12 months?
Bellerophon lowest stock price was $0.67 and its highest was $12.58 in the past 12 months.
What is Bellerophon’s market cap?
Currently, no data Available
When is Bellerophon’s upcoming earnings report date?
Bellerophon’s upcoming earnings report date is Aug 03, 2023 which is in 62 days.
How were Bellerophon’s earnings last quarter?
Currently, no data Available
Is Bellerophon overvalued?
According to Wall Street analysts Bellerophon’s price is currently Undervalued.
Does Bellerophon pay dividends?
Bellerophon does not currently pay dividends.
What is Bellerophon’s EPS estimate?
Bellerophon’s EPS estimate is -$0.46.
How many shares outstanding does Bellerophon have?
Bellerophon has 10,449,834 shares outstanding.
What happened to Bellerophon’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bellerophon?
Among the largest hedge funds holding Bellerophon’s share is Perceptive Advisors LLC. It holds Bellerophon’s shares valued at 7M.
---
Bellerophon Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.50 (371.70% Upside)
$32.50 (371.70% Upside)
Blogger Sentiment
Bullish
BLPH Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 930.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.1%
Last 30 Days ▼ 0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
526.36%
12-Months-Change
Fundamentals
Return on Equity
-84.92%
Trailing 12-Months
Asset Growth
-26.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Bellerophon
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.
---
Top 5 ETFs holding BLPH
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold BLPH. The ETFs are listed according to market value of BLPH within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---